Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewAffirma Biotech closes a seed round of 600.000 EUR to continue with the proof of concept o...
Affirma Biotech, a start-up based in Sant Pau’s Hospital, was incorporated in September 2020 by Maribel Berges and Joan Feixas to develop new treatments against chronic infections
-
New#NewMember | "AseBio is both the place to meet other companies in the industry and the voi...
Meet Affirma Biotech, our new member. We talked to Maribel Berges, CEO of the company.
-
NewUn nuevo enfoque para el tratamiento de la tormenta de citoquinas asociada a infecciones
La tormenta de citoquinas asociada a procesos infecciosos severos es un problema grave de salud mundial pero aún no existe un fármaco para su tratamiento
-
NewBiotechnology also looks after your skin
Having just returned from the summer break, and consequently from exposing our bodies to the sun, we talked to two biotechnology companies who are searching for solutions to protect our skin using
-
NewORYZON to present preliminary blinded aggregate safety data from vafidemstat’s ongoing Pha...
At the 10th European Conference on Mental Health (ECMH)
-
CompanyMiMARK diagnostics
-
NewEl Workshop ALGAENAUTS concluye descubriendo la gran potencialidad de las microalgas
Tras el workshop organizado por Biorizon Biotech, en el marco de su proyecto europeo ALGAENAUTS, sobre las microalgas y su papel en la economía azul, se vio cómo contribuyen al desarrollo económico y
-
NewInsud Pharma pone en marcha la VI Edición de su programa Chemostart para startups innovado...
El programa ChemoStart es una iniciativa liderada por Leandro Sigman junto con un total de 25 mentores y expertos en salud
-
NewAsabys launches a new €200M fund to invest in biotech & healthtech
SAHII 2 will invest in digital health, medtech and biotech companies, developing disruptive solutions with solid scientific evidence to improve patient outcomes
-
NewMinoryx presenta la solicitud de autorización de comercialización de su fármaco leriglita...
La adrenoleucodistrofia ligada al cromosoma X (X-ALD) es una enfermedad minoritaria y neurodegenerativa para la cual no existe tratamiento
-
NewAyming refuerza su actividad en España con una nueva sede en Bilbao
La compañía suma su nueva sede de Bilbao a su presencia en Madrid, Barcelona y Valencia
-
New3P Biopharmaceuticals nombra a Kenneth McMahon como Jefe de Control de Calidad
Se incorporará como apoyo a la dirección del departamento de control de calidad
-
-
NewAseBio joins the ShapingBio project to accelerate innovation in Europe's bioeconomy
The initiative, which includes entities from a dozen countries, aims to find responses to European climate priorities with bio-based products.
-
-
NewSchülke & Mayr GmbH acquires Spanish company Vesismin Health
Schülke & Mayr GmbH, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, acquires Vesismin Health, based in the Barcelona Science Park. The Spanish
-
-
EventApply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition"
¡Deadline extended! You can apply until October 5th
-
NewConsituido el jurado de la III Edición de los Premios Zendal que galardonará a investigaci...
El jurado está formado por 5 expertos en el ámbito de la salud y dos directivos del grupo Zendal
-
New#NewMemberAseBio | "AseBio is the door to the networking with key relevant stakeholders in...
Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company.
-
NewOnly 1 in 3 cancer patients protect their skin from the sun every day of the year
Some cancer therapies can affect the skin, making extra protection from the sun necessary during and after cancer treatment
